Logo
Home
Archive
Recommendations
Log in
Subscribe

ARCHIVE


FDA Wants Your Trial Data in Real Time — and Your 483 Response in 15 Days

May 4, 2026

•

23 min read

FDA Wants Your Trial Data in Real Time — and Your 483 Response in 15 Days

Plus: a genomic data lawsuit names AstraZeneca, BMS, GSK, and Pfizer; Lilly bets $2.25B on AI-designed gene editing; and only 17% of pharma orgs have demonstrated AI value in discovery

"The AI Didn't Tell Me" Is Not a Compliance Defense. Merck Bets $1B Anyway.

Apr 27, 2026

•

25 min read

"The AI Didn't Tell Me" Is Not a Compliance Defense. Merck Bets $1B Anyway.

FDA's first AI warning letter sets a sector-wide precedent; Merck–Google redefines pharma AI architecture; Oracle Life Sciences InForm needs a P1 patch now.

2,200 FDA Letters, a 240-Day HIPAA Countdown, and the Cybersecurity Gap That Money Can't Fix

Apr 20, 2026

•

26 min read

2,200 FDA Letters, a 240-Day HIPAA Countdown, and the Cybersecurity Gap That Money Can't Fix

Three enforcement actions, one structural problem, and why Novo Nordisk's OpenAI deal is the operating model benchmark your board will reference

Your AI Vendor Is Now an R&D Actor — and 60% of Pilots Are Proving the Operating Model Isn't Ready

Apr 13, 2026

•

2 min read

Your AI Vendor Is Now an R&D Actor — and 60% of Pilots Are Proving the Operating Model Isn't Ready

Anthropic acquires Coefficient Bio, ZS puts the pilot-to-scale failure rate at 60%, and Health-ISAC warns that geopolitical escalation has healthcare in its crosshairs

A $2.75B AI Bet, a 2.3/5 Governance Score, and Regulators Running Out of Patience

Apr 6, 2026

•

2 min read

A $2.75B AI Bet, a 2.3/5 Governance Score, and Regulators Running Out of Patience

Lilly's landmark deal resets the AI benchmark — the same week McKinsey data and converging FDA/EMA frameworks reveal how far most organizations have to close

FDA Sends a Warning, Agentic AI Goes Enterprise, and the Capital Squeeze That Makes Both Harder

Mar 30, 2026

•

2 min read

FDA Sends a Warning, Agentic AI Goes Enterprise, and the Capital Squeeze That Makes Both Harder

Novo Nordisk's pharmacovigilance failure, Verily's $300M raise, and new data showing AI training investments aren't working

The AI Arms Race Is Real, the Attack Surface Just Got Bigger, and 78% of Life Sciences Is Still Behind

Mar 23, 2026

•

1 min read

The AI Arms Race Is Real, the Attack Surface Just Got Bigger, and 78% of Life Sciences Is Still Behind

Roche raises the infrastructure bar, Stryker shows the cost of endpoint exposure, and Deloitte counts how few firms have actually scaled AI

Life Sciences CIO Weekly Digest - Week of March 9-15, 2026 [Updated]

Mar 19, 2026

•

1 min read

Life Sciences CIO Weekly Digest - Week of March 9-15, 2026 [Updated]

Week of March 9-15, 2026 • Updated Edition

Nation-state wiper, SUD enforcement, and the AI orchestration mandate

Mar 16, 2026

•

1 min read

Nation-state wiper, SUD enforcement, and the AI orchestration mandate

Stryker's 200,000 wiped devices, OCR's new SUD civil penalties, and why boards are now grading CIOs on AI ROI — not experimentation

Load more posts
arrow-right

CIOs Industry News for Life Sciences

Curated weekly digest of technology trends, regulatory updates, and industry developments specifically for life sciences CIOs and IT leaders. Get actionable insights on AI innovation, compliance requirements, cybersecurity threats, and R&D technology advances—all filtered through the lens of biotech and biopharma operations. Delivered every week with trusted sources and practical takeaways to help you stay ahead of the curve and lead with confidence.

© 2026 A publication of Leadership Inklings, Inc..
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv